SCHEMBL295795

SCHEMBL295795

C1CC[C]2CCC2CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7391293 1.00 KMT2A (0.33)
SCHEMBL35115 1.00 KMT2A (0.33)
SCHEMBL70819 0.97
SCHEMBL542776 0.94 KMT2A (0.36)
SCHEMBL9956415 0.94 KMT2A (0.36)
SCHEMBL25327994 0.94 KMT2A (0.36)
SCHEMBL13858690 0.94 KMT2A (0.36)
SCHEMBL11594630 0.94 KMT2A (0.36)
SCHEMBL7737845 0.94 KMT2A (0.36)
SCHEMBL7992221 0.94 KMT2A (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014028669-A1 NOVEL COMPOUNDS FOR MODULATION OF ROR-GAMMA ACTIVITY BIOGEN IDEC MA INC. (US) 2014-02-20 WO claimed
US-20120184556-A1 SUBSTITUTED ENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-07-19 US claimed
EP-2456310-A1 SUBSTITUTED BENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS Vanderbilt University (US) 2012-05-30 EP claimed
WO-2011011722-A1 SUBSTITUTED BENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS VANDERBILT UNIVERSITY (US) 2011-01-27 WO claimed
US-20090256468-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-10-15 US claimed
US-20090230852-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-09-17 US claimed
EP-2100941-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-09-16 EP claimed
EP-2096108-A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same Gracel Display Inc. (KR) 2009-09-02 EP claimed
EP-1399431-B1 NOVEL NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMA (US) 2009-02-18 EP claimed
US-6982263-B2 Nitriles useful as reversible inhibitors of cysteine proteases BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2006-01-03 US claimed
US-20040152132-A1 Solid phase synthesis of LXR ligands TULARIK INC. 2004-08-05 US claimed
US-6673543-B2 JOINING LIVER RECEPTORS TO SOLID SUPPORT; GENERATE SOLID SUPPORT, JOIN ANILINE DERIVATIVE TO SUPPORT, INCUBATE WITH ALDEHYE, KETONE, INCUBATE ANILINE DERIVATIVE WITH ACYLATING AGENT, RECOVER SUPPORT TULARIK, INC. 2004-01-06 US claimed
US-20030119827-A1 Novel nitriles useful as reversible inhibitors of cysteine proteases BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2003-06-26 US claimed
WO-2002100849-A2 NOVEL NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2002-12-19 WO claimed
US-20020072073-A1 Solid phase synthesis of LXR ligands AMGEN INC. 2002-06-13 US claimed
WO-2001077067-A2 SOLID PHASE SYNTHESIS OF LXR LIGANDS TULARIK INC. (US) 2001-10-18 WO claimed
US-5294531-A BicycloUm.n.oealkane-1-ylcarbonylacetamide compound FUJI PHOTO FILM CO., LTD. (JP) 1994-03-15 US claimed
WO-2024149340-A1 INDOLONE DERIVATIVE HAVING IRAK4 INHIBITORY ACTIVITY, AND PREPARATION METHOD THEREFOR AND USE THEREOF 深圳众格生物科技有限公司 2024-07-18 WO disclosed
EP-0268554-A2 1,5-Diphenyl pyrazole-3-carbonic-acid derivatives for the protection of cultured plants CIBA-GEIGY AG (CH) 1988-05-25 EP disclosed
EP-0191736-A2 Use of quinoline derivatives for the protection of crop plants CIBA-GEIGY AG (CH) 1986-08-20 EP disclosed